Publications found:
1,234
Sort by:
Intratumoral Cancer Therapies Market - 2025-2033
US$ 3,400.00
Intratumoral Cancer Therapies Market reached US$ 219.79 million in 2023 and is expected to reach US$ 630.7 million by 2033, growing with a CAGR of 11.00% during the forecast period 2026-2033. The Intr...
December 2025
55 pages
Proton Therapy Systems Market - 2024-2031
US$ 3,400.00
The Proton Therapy Systems Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
December 2025
48 pages
Head And Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Immunotherapy), By Route Of Administration, By Distribution Channel (Hospital Pharmacies, Online Pharmacies), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... , radiation therapy, chemotherapy, and immunotherapy in the head and neck cancer therapeutics market. Major challenges faced by this patient population ... drug delivery approaches to improve overall survival rates Among EU5, Germany captured the top position in the global head and neck cancer therapeutics ...
December 2025
150 pages
HER2+ Gastric Cancer Market - 2024-2031
US$ 3,400.00
The HER2+ Gastric Cancer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
December 2025
46 pages
Keytruda Market Size, Share & Trends Analysis Report By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global Keytruda market size was estimated at USD 31.38 billion in 2025 and is projected to reach USD 24.95 billion by 2033, declining at a CAGR of -3.80% from 2026 to 2033. The market outlook for...
December 2025
150 pages
Ovarian Cancer Drugs Market - 2025-2033
US$ 3,400.00
Ovarian Cancer Drugs Market reached US$ 3.81 billion in 2024 and is expected to reach US$ 6.72 billion by 2033, growing with a CAGR of 6.60% during the forecast period 2026-2033. The Ovarian Cancer Dr...
December 2025
46 pages
Prostate Cancer Drugs Market - 2025-2033
US$ 3,400.00
Prostate Cancer Drugs Market reached US$ 13.22 Billion in 2024 and is expected to reach US$ 28.10 Billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033. The Prostate Cance...
December 2025
47 pages
US & EU Melanoma Therapeutics Market - 2025-2033
US$ 3,400.00
US & EU Melanoma Therapeutics Market reached US$ 3.89 billion in 2024 and is expected to reach US$ 8.99 billion by 2033, growing with a CAGR of 9.80% during the forecast period 2026-2033. The US & EU...
December 2025
55 pages
Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedures (Tumor Biopsy, Vascular Interventions), By Application (Lung Cancer, Kidney Cancer), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global interventional oncology market size was estimated at USD 2.90 billion in 2025 and is projected to reach USD 5.61 billion by 2033, growing at a CAGR of 8.59% from 2026 to 2033. This growth...
December 2025
210 pages
Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration), By End Users (Hospitals & Clinics, Ambulatory Care centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, valued at USD 14.38 Billion in 2024, is projected to experience a CAGR of 3.65% to reach USD 17.83 Billion by 2030. Anti-vascula...
December 2025
185 pages
Chronic Lymphocytic Leukemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Aggressive CLL, Indolent CLL, Others), By Treatment (Targeted Drug Therapy, Chemotherapy, Bone Marrow Transplant, Immunotherapy), By Route of Administration (Oral, Parental, Others), By End user (Hospital, Diagnostic Laboratories, Research Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Chronic Lymphocytic Leukemia Treatment Market will grow from USD 13.37 Billion in 2024 to USD 21.51 Billion by 2030 at a 8.25% CAGR. The global chronic lymphocytic leukemia (CLL) treatment...
December 2025
185 pages
Melanoma Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Type (Superficial Spreading Melanoma, Lentigo Maligna, Acral Lentiginous Melanoma, Nodular Melanoma), By Application (Hospitals, Outpatient Oncologist Clinics, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Melanoma Drugs Market will grow from USD 7.42 Billion in 2024 to USD 11.98 Billion by 2030 at a 8.31% CAGR. Melanoma drugs refer to pharmaceutical agents developed to treat melanoma, an agg...
December 2025
185 pages
Myeloproliferative Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Hyper eosinophilic Syndrome, Systemic Masto cytosis), By Drug Type (JAK2 Inhibitors, Anti-Neoplastic, Demethylation Agents, Imatinib Mesylate, Others), By Route of Administration (Oral, Parental, Others), By Distribution Channel (Hospital Pharmacy, Retail Stores, Drug Stores), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Myeloproliferative Disorders Drugs Market will grow from USD 9.94 Billion in 2024 to USD 14.06 Billion by 2030 at a 5.95% CAGR. Myeloproliferative Disorders (MPDs) drugs comprise a speciali...
December 2025
185 pages
Tyrosine Kinase Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Other), By Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Other), By Region, By Competition, 2020-2030F
US$ 4,500.00
The Global Tyrosine Kinase Inhibitors Market will grow from USD 52.07 Billion in 2024 to USD 83.09 Billion by 2030 at a 8.10% CAGR. Tyrosine Kinase Inhibitors, or TKIs, are a class of pharmaceutical d...
December 2025
183 pages
Angiosarcoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Hemangiosarcoma, Lymphangiosarcoma, Parenchymal Angiosarcoma), By Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others), By End user (Hospital & Clinics, Ambulatory Surgical Centers, Online Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Angiosarcoma Treatment Market , valued at USD 280.11 Million in 2024, is projected to experience a CAGR of 6.11% to reach USD 399.85 Million by 2030. Angiosarcoma treatment encompasses a ra...
December 2025
180 pages
Precision Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies) Region and Competition, 2020-2030F
US$ 4,500.00
The Global Precision Oncology Market , valued at USD 99.45 Billion in 2024, is projected to experience a CAGR of 9.12% to reach USD 167.87 Billion by 2030. Precision oncology tailors cancer treatment...
December 2025
183 pages
Acute Myeloid Leukemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, hormonal therapy, and other chemotherapies), By Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Acute Myeloid Leukemia Market, valued at USD 1.56 Billion in 2024, is projected to experience a CAGR of 8.90% to reach USD 2.63 Billion by 2030. Acute Myeloid Leukemia (AML) is a rapidly pr...
December 2025
183 pages
Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Hormonal Therapy, Targeted Therapy, Chemotherapy, Immunotherapy), By Cancer Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global breast cancer drugs market size was estimated at USD 36.62 billion in 2024 and is projected to reach USD 69.72 billion by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market is...
December 2025
150 pages
Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (B-cell Lymphomas, T-cell Lymphoma), By Drug Class (Monoclonal Antibodies, Antibody-Drug Conjugates, BTK/BCL-2 Kinase Inhibitors, PI3 Kinase Inhibitors, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Non-Hodgkin Lymphoma Market, valued at USD 7.24 Billion in 2024, is projected to experience a CAGR of 7.72% to reach USD 11.31 Billion by 2030. The global Non-Hodgkin Lymphoma market compri...
November 2025
187 pages
Global Hepatocellular Carcinoma Market - 2024–2031
US$ 3,400.00
Global Hepatocellular Carcinoma Market reached USD 977 million in 2022 and is expected to reach USD 2.4 billion by 2031, growing with a CAGR of 12.20% during the forecast period 2026-2031. The Global...
November 2025
57 pages
Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Breast Cancer, Blood Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Lung Cancer, Others), By Drug (Cytotoxic, Hormonal Therapy, Targeted Therapy, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anticancer Drug Market, valued at USD 179.93 Billion in 2024, is projected to experience a CAGR of 5.25% to reach USD 244.59 Billion by 2030. Anticancer drugs represent pharmaceutical agent...
November 2025
185 pages
Non-Hodgkin Lymphoma (NHL) Therapeutics Market By Type of Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Stem Cell Transplant, Others), By Cell Type (B-cell Lymphomas, T-cell Lymphomas), By Drug Type (Revlimid, Rituxan, Keytruda, Imbruvica, Opdivo, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 4,500.00
The Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market , valued at USD 8.19 Billion in 2024, is projected to experience a CAGR of 7.61% to reach USD 12.72 Billion by 2030. Non-Hodgkin Lymphoma (NHL...
November 2025
180 pages
Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Oncology Drugs Market, valued at USD 228.65 Billion in 2024, is projected to experience a CAGR of 13.33% to reach USD 484.54 Billion by 2030. Oncology drugs are pharmaceutical agents develo...
November 2025
185 pages
Breast Cancer Drugs Market - 2025-2031
US$ 3,400.00
Breast Cancer Drugs Market reached USD 32.4 billion in 2024 and is expected to reach USD 57.1 billion by 2031, growing with a CAGR of 9.20% during the forecast period 2026-2031. The Breast Cancer Drug...
November 2025
45 pages
Gastrointestinal Cancer Drugs Market - 2025-2031
US$ 3,400.00
Gastrointestinal Cancer Drugs Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Gastrointestinal Cancer Drugs Market emerges as a key focus in DataM Intelligence lates...
November 2025
55 pages
Oncolytic Virus Therapy Market - 2025-2033
US$ 3,400.00
Oncolytic Virus Therapy Market reached US$ 27.33 Million in 2024 and is expected to reach US$ 199.98 Million by 2033, growing with a CAGR of 24.90% during the forecast period 2026-2033. The Oncolytic...
November 2025
49 pages
Cancer Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Application (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer, Others)
US$ 3,950.00
The Cancer Drugs Market is valued at USD 267 billion in 2025 and is projected to grow at a CAGR of 14.3% to reach USD 889.1 billion by 2034. Cancer Drugs Market The Cancer Drugs Market encompasses tar...
November 2025
160 pages
CAR T cell Therapy Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease Indication (Leukemia, Lymphoma, Multiple Myeloma, Others), By End-User
US$ 3,950.00
The CAR T cell Therapy Market is valued at USD 5.72 billion in 2025 and is projected to grow at a CAGR of 28% to reach USD 52.76 billion by 2034. CAR T cell Therapy Market CAR?T cell therapy refers to...
November 2025
160 pages
Keytruda Market Outlook 2026-2034: Market Share, and Growth Analysis By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma, Head and Neck Cancer, Gastric Cancer, Urothelial Cancer, Others), By Payer (Commercial/Private, Public), By Distribution Channel
US$ 3,950.00
The Keytruda Market is valued at USD 29.87 billion in 2025 and is projected to grow at a CAGR of 9% to reach USD 64.87 billion by 2034. Keytruda Market Keytruda (pembrolizumab) has evolved into a corn...
November 2025
160 pages
Testicular Cancer Drugs Market Size, Share & Trends Analysis Report By Drug Class (Platinum Compounds, Alkylating Agents), By Disease Type (Seminoma, Non-Seminomatous Germ Cell Tumors), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global testicular cancer drugs market size was estimated at USD 1.08 billion in 2024 and is projected to reach USD 1.97 billion by 2033, growing at a CAGR of 6.9% from 2025 to 2033. The market is...
November 2025
150 pages
Hadron Therapy Market - 2024-2031
US$ 3,400.00
Hadron Therapy Marketis is growing with a CAGR of 10.00% during the forecast period 2026-2035. The Hadron Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where se...
November 2025
40 pages
Cancer Cachexia Market Size, Share & Trends Analysis Report By Treatment (Appetite Stimulants, Corticosteroids), By Type (Lung Cancer, Colorectal Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global cancer cachexia market size was estimated at USD 2.54 billion in 2024 and is projected to reach USD 3.90 billion by 2033, growing at a CAGR of 4.86% from 2025 to 2033. The rising cancer inc...
November 2025
150 pages
Bevacizumab Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Avastin, Mvasi, Zirabev, Aybintio, Other Products), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application
US$ 3,950.00
The Bevacizumab Biosimilars Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 8.3% to reach USD 4.3 billion by 2034.The bevacizumab biosimilars market is rapidly growin...
October 2025
160 pages
Checkpoint Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, Other Drugs), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma, Other Applications), By End-Users
US$ 3,950.00
The Checkpoint Inhibitors Market is valued at USD 36.8 billion in 2025 and is projected to grow at a CAGR of 19.1% to reach USD 177.4 billion by 2034. The checkpoint inhibitors market has emerged as a...
October 2025
160 pages
Chemotherapy-Induced Nausea And Vomiting (Cinv) Market Outlook 2025-2034: Market Share, and Growth Analysis By Form (Injectables, Oral, Transdermal Patches), By Drug Class (5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class), By Emetogenic Risk, By Distribution Channel, By Application
US$ 3,950.00
The Chemotherapy-Induced Nausea And Vomiting (Cinv) Market is valued at USD 3.7 billion in 2025 and is projected to grow at a CAGR of 7.9% to reach USD 7.3 billion by 2034.The Chemotherapy-Induced Nau...
October 2025
160 pages
